{domain:"www.qualitydigest.com",server:"169.47.211.87"} Skip to main content

        
User account menu
Main navigation
  • Topics
    • Customer Care
    • FDA Compliance
    • Healthcare
    • Innovation
    • Lean
    • Management
    • Metrology
    • Operations
    • Risk Management
    • Roadshow
    • Six Sigma
    • Standards
    • Statistics
    • Supply Chain
    • Sustainability
    • Training
  • Videos/Webinars
    • All videos
    • Product Demos
    • Webinars
  • Advertise
    • Advertise
    • Submit B2B Press Release
    • Write for us
  • Metrology Hub
  • Training
  • Subscribe
  • Log in
Mobile Menu
  • Home
  • Topics
    • 3D Metrology-CMSC
    • Customer Care
    • FDA Compliance
    • Healthcare
    • Innovation
    • Lean
    • Management
    • Metrology
    • Operations
    • Risk Management
    • Roadshow
    • Six Sigma
    • Standards
    • Statistics
    • Supply Chain
    • Sustainability
    • Training
  • Login / Subscribe
  • More...
    • All Features
    • All News
    • All Videos
    • Training

Measuring Continuity of Patient Care

  • Read more about Measuring Continuity of Patient Care
  • Add new comment

Measurements of patient care continuity should encompass all of the components of health care delivery—structure, process, and outcome. “Structure” in health care delivery refers to the way a health care entity organizes itself and sets up operations.

Metris K-Series qualifies RCR chassis for NASCAR victory

Terms of Use
I agree to the terms of use:
  • Read more about Metris K-Series qualifies RCR chassis for NASCAR victory

To cut seconds off lap times, RCR engineers use Metris metrology equipment to optimize and tune the chassis/suspension performance of their premium race vehicles. Metris K-Series allows a complete chassis build to be referenced from a single common coordinate system, increasing data capture efficiency with over 40%. Higher metrology performance, precision and repeatability secure NASCAR chassis certification and strengthen RCR chassis engineering and manufacturing expertise.

To Root Or Not To Root: Part 2

  • Read more about To Root Or Not To Root: Part 2
  • Add new comment

Part one of “To Root Or Not To Root,”presented a dilemma that many managers face all too often. Regardless of approach, does a problem warrant a full-blown root cause analysis?

It’s Time For Heads To Roll!

  • Read more about It’s Time For Heads To Roll!
  • 1 comment
  • Add new comment

One of my favorite movies is a dark gangster movie starring Joe Pesci entitled "8 Heads in A Duffel Bag." Pesci, a mob courier is hired to transport the heads of eight murder victims to a mafia boss to prove that the “hits” had in fact taken place.

CRM - Worth the Investment?

Terms of Use
I agree to the terms of use:
  • Read more about CRM - Worth the Investment?

This is a white paper designed to help Business Owners, Executives, and IT leaders how to justify the benefits of a CRM software system for their company.

How to Stand Out in the Crowd

  • Read more about How to Stand Out in the Crowd
  • Add new comment

In the world of marketing and branding, sticking out like a sore thumb isn’t necessarily bad, advises brand innovation specialist Chandran Dharmarajan, a co-founder of I-morph, a marketing innovation consultancy based in Singapore.

PDA-FDA Pharmaceutical Supply Chain Conference

  • Read more about PDA-FDA Pharmaceutical Supply Chain Conference
  • Add new comment

(FDA: Rockville, Maryland) -- To learn about the development of global initiatives to ensure the integrity of the Pharmaceutical Supply Chain, join regulatory and industry representatives from at the PDA-FDA Pharmaceutical Ingredient Supply Chain Conference, December 3-5, 2008 at Loews Coro

FDA Opens Office in China

  • Read more about FDA Opens Office in China
  • Add new comment

(HHS: Washington) -- As part of an ongoing strategy to address the food safety issues in China and the United States, and to share ideas to address global food safety, the U.S. Food and Drug Administration (FDA) opened its first office in Beijing, China, on Nov. 19, 2008. The U.S.

The Advancement of Controlled Clinical Trials

  • Read more about The Advancement of Controlled Clinical Trials
  • Add new comment

From an antacid to a new cancer treatment, every drug must be proven safe and effective in controlled clinical trials before the U.S. Food and Drug Administration (FDA) allows it to be sold in the United States.

Improving Import Safety

  • Read more about Improving Import Safety
  • Add new comment

(HHS: Washington) -- Last year, the United States imported more than $2 trillion worth of products, from roughly 825,000 importers, through more than 300 ports of entry.

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 1746
  • Page 1747
  • Page 1748
  • Page 1749
  • Current page 1750
  • Page 1751
  • Page 1752
  • Page 1753
  • Page 1754
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

© 2025 Quality Digest. Copyright on content held by Quality Digest or by individual authors. Contact Quality Digest for reprint information.
“Quality Digest" is a trademark owned by Quality Circle Institute Inc.

footer
  • Home
  • Print QD: 1995-2008
  • Print QD: 2008-2009
  • Videos
  • Privacy Policy
  • Write for us
footer second menu
  • Subscribe to Quality Digest
  • About Us